Mononuclear phagocyte system

From WikiMD's WELLNESSPEDIA

Mononuclear phagocyte system (MPS), also known as the reticuloendothelial system (RES), is a part of the immune system that consists of phagocytic cells located in reticular connective tissue. The cells are primarily monocytes and macrophages, and they accumulate in lymph nodes and the spleen. The Kupffer cells of the liver and tissue histiocytes are also part of the MPS.

Function[edit]

The primary function of the MPS is the phagocytosis, or engulfing and then digesting, of cellular debris and pathogens. Additionally, the MPS is responsible for the development and release of monocytes and macrophages, important immune cells that are capable of destroying pathogens through phagocytosis.

Components[edit]

The MPS is composed of monocytes and macrophages. Monocytes are produced in the bone marrow and released into the blood. They have a short half-life in the blood (about 1 to 3 days), after which they migrate to tissues and develop into different types of macrophages.

Macrophages are found in all tissues and are the primary cells of the MPS. They are responsible for phagocytosing pathogens and dead cells, and they also help to stimulate the immune response by presenting antigens to T cells and releasing cytokines.

Clinical significance[edit]

The MPS plays a crucial role in host defense against infections. Defects in the MPS can lead to increased susceptibility to infections. In addition, the MPS is involved in the pathogenesis of certain diseases such as atherosclerosis, rheumatoid arthritis, and cancer.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.